AHR and Increased total eosinophil count: HDM-treated C57BL/6Mthfr-/- mice demonstrated a suppressed allergic airway disease phenotype compared to HDM-treated C57BL/6 mice including reduced AHR (Fig 2A) and decreased cellularity and eosinophilia in WLL (Fig 2B–2D).